NCT01868542 - A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Insulin detemir was administered once daily to the subjects. The dose was titrated based on the previous breakfast SMPG values.

Trial Locations (6)